Sleep Hygiene and Insomnia: What the Evidence Says

Quick Answer

Sleep Hygiene and Insomnia has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, guideline, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 systematic review, 1 guideline.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Insomnia causes significant distress, functional impairment, and increases health care costs and risk for other disorders. [Buysse Daniel J. (2026); evidence level 1]
• Current clinical practice guidelines (CPGs) recommend behavioral-psychological treatment and medications as single treatment modalities for insomnia. [Buysse Daniel J. (2026); evidence level 1]
• This clinical practice guideline (CPG) provides an American Academy of Sleep Medicine (AASM) guideline on combination treatment of chronic insomnia in adults and reflects the current recommendations of the AASM. [Buysse Daniel J. (2026); evidence level 2]
• However, evidence-based guidance regarding the benefits and harms of combination treatment for chronic insomnia is lacking. [Buysse Daniel J. (2026); evidence level 2]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For sleep hygiene insomnia guideline, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Buysse Daniel J. (2026). Combination treatment for chronic insomnia disorder in adults: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment. DOI: 10.1007/s44470-025-00039-7. PMCID: PMC13083734. PMID: 41986788. License: https://creativecommons.org/licenses/by-nc-nd/4.0/ http://creativecommons.org/licenses/by-nc-nd/4.0/ This article is .... https://pmc.ncbi.nlm.nih.gov/articles/PMC13083734/
• Buysse Daniel J. (2026). Combination treatment for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline. DOI: 10.1007/s44470-025-00038-8. PMCID: PMC13076838. PMID: 41975142. License: https://creativecommons.org/licenses/by-nc-nd/4.0/ http://creativecommons.org/licenses/by-nc-nd/4.0/ This article is .... https://pmc.ncbi.nlm.nih.gov/articles/PMC13076838/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.